Results 221 to 230 of about 2,266,049 (248)

Safety and Efficacy of Deucravacitinib in Japanese Patients With Moderate to Severe Plaque Psoriasis: 5‐Year Analysis of the Phase 3 POETYK PSO‐1, PSO‐4, and Long‐Term Extension Trials

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, is approved in multiple countries for the treatment of moderate to severe plaque psoriasis, as well as generalized pustular and erythrodermic psoriasis in Japan. Deucravacitinib 6 mg once daily was efficacious and well tolerated through 3 years in the pooled population of ...
Yukari Okubo   +12 more
wiley   +1 more source

How to perform Doppler examination of the maternal ophthalmic artery

open access: yes
Ultrasound in Obstetrics &Gynecology, EarlyView.
A. Youssef, M. Paoli, K. H. Nicolaides
wiley   +1 more source

Limited Efficacy of Autologous Mesenchymal Stromal Cell Injections in Immunomodulatory-Dependent Dogs With Aqueous Deficient Dry Eye Disease. [PDF]

open access: yesVet Ophthalmol
Leonard BC   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy